Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
5 minutes with... Dr Matthew Hickling, Allergan Aesthetics
Dr Matthew Hickling explores the science behind beauty, his role in aesthetics and the opportunities shaping the future of the field.
The HBA crowns its '2025 Woman of the Year'
The Healthcare Businesswomen’s Association (HBA) has announced its 2025 winners as Reshema Kemps-Polanco, Executive Vice President and Chief Commercial Officer, Novartis US.
The changing face of field medical affairs
There are many pillars of medical affairs, but field teams are where the action happens. How do you build teams that deliver results?
Robeauté’s microbot brain technology secures $28m
The company’s microbot technology holds huge potential for exploring and delivering treatments to the brain.
Needle-free vaccine technology wins $3.7m in funding from CEPI
Micron Biomedical, an Atlanta-based life sciences company, has received funding for its technology that could improve vaccine access.
WuXi Biologics offloads Irish vaccine plant to Merck for $500m
WuXi Biologics sells its vaccine production facility in Ireland to Merck & Co for $500m in the wake of changing regulation in the US.
Spoonful of technology: Nov-Dec 2024
Discover the latest examples of how pharma and its partners are working together to develop technology to solve key industry challenges.
Spotlight: December 2024
Catch up on all the latest pharmaceutical industry news from the past month, from breakthroughs in gene therapy to promising drug approvals and more.
Pharma review of the year 2024
Look back at the key moments from the past year in pharma with three of our former guests, as they highlight key trends, challenges and more.
Eli Lilly’s tirzepatide wins FDA nod for sleep apnea
Eli Lilly’s weight-loss drug tirzepatide has become the first drug for obstructive sleep apnea, a common but serious sleep disorder.
←
1
2
3
4
5
6
7
8
9
…
27
28
29
→
We’ve noticed you’re accessing
from
North/South America.
View
View